Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31
University of California, Los Angeles · RTOG Foundation · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
920
total citations
- FWCI
- 48.97
- Percentile
- 100%
- References
- 20
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Medicine
- Goserelin
- Prostatectomy
- Urology
- Radiation therapy
- Androgen suppression
- Prostate
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.